IPO Trending
CORONAEQ / NSE, BSEListed

Corona Remedies Limited

Corona Remedies Limited, incorporated in August 2004, is a pharmaceutical company engaged in the development, manufacturing, and marketing of products across key therapeutic areas including women’s healthcare, cardiology, pain management, urology, and multispecialty segments. As of December 2024, its portfolio includes 67 brands covering women’s health, cardio-diabetic care, pain relief, urology, and multispecialty products such as vitamins, minerals, nutrition, gastrointestinal, and respiratory medications. The company has established a strong pan-India presence with 2,598 medical representatives across 22 states, ensuring deep engagement with healthcare professionals and hospitals. It operates two manufacturing facilities in Gujarat, supporting its production and quality-focused growth strategy in the Indian Pharmaceutical Market.

₹1,008 - ₹1,062144.49x sub
Listed Price1470.00
Listing Gain+38.42%
ProspectusOfficial exchange filings and draft red herring documents
Corona Remedies Limited IPO Documents | GMP, Allotment & Financials | IPO Trending